Skip to main content

Table 2 Distribution of HPV genotypes found in the study according to the pathological diagnosis

From: Human papillomavirus genotypes in human immunodeficiency virus-positive patients with anal pathology in Madrid, Spain

Genotype found

Total lesions

LASIL

HASIL

 

N

% *

CI95%

% **

CI95%

N

% *

CI95%

% **

CI95%

N

% *

CI95%

% **

CI95%

HR-HPVs

               

16

23

10.3

6.6-15.1

37.1

25.2-50.3

12

8.5

4.5-14.4

30.0

16.6-46.5

10

12.7

6.2-22.0

50.0

27.2-72.8

18

2

0.9

0.1-3.2

3.2

0.4-11.2

0

0.0

0.0-2.6

0.0

0.0-8.8

2

2.5

0.3-8.8

10.0

1.2-31.7

31

13

5.8

3.1-9.8

21.0

11.7-33.2

7

5.0

2.0-10.0

17.5

7.3-32.8

6

7.6

2.8-15.8

30.0

11.9-54.3

33

6

2.7

1.0-5.8

9.7

3.6-19.9

2

1.4

0.2-5.0

5.0

0.6-16.9

4

5.1

1.4-12.5

20.0

5.7-43.7

35

5

2.2

0.7-5.2

8.1

2.7-17.8

3

2.1

0.4-6.1

7.5

1.6-20.4

2

2.5

0.3-8.8

10.0

1.2-31.7

39

5

2.2

0.7-5.2

8.1

2.7-17.8

4

2.8

0.8-7.1

10.0

2.8-23.7

1

1.3

0.0-6.9

5.0

0.1-24.9

45

8

3.6

1.6-6.9

12.9

5.7-23.9

6

4.3

1.6-9.0

15.0

5.7-29.8

2

2.5

0.3-8.8

10.0

1.2-31.7

51

14

6.3

3.5-10.3

22.6

12.9-35.0

10

7.1

3.5-12.7

25.0

12.7-41.2

4

5.1

1.4-12.5

20.0

5.7-43.7

52

19

8.5

5.2-13.0

30.6

19.6-43.7

13

9.2

5.0-15.3

32.5

18.6-49.1

6

7.6

2.8-15.8

30.0

11.9-54.3

56

5

2.2

0.7-5.1

8.1

2.7-17.8

4

2.8

0.8-7.1

10.0

2.8-23.7

1

1.3

0.0-6.9

5.0

0.1-24.9

58

13

5.8

3.1-9.8

21.0

11.7-33.2

6

4.3

1.6-9.0

15.0

5.7-29.8

7

8.9

3.6-17.4

35.0

15.4-59.2

59

7

3.1

1.3-6.4

11.3

4.7-21.9

3

2.1

0.4-6.1

7.5

1.6-20.4

4

5.1

1.4-12.5

20.0

5.7-43.7

73

5

2.2

0.7-5.1

8.1

2.7-17.8

4

2.8

0.8-7.1

10.0

2.8-23.7

1

1.3

0.0-6.9

5.0

0.1-24.9

81

5

2.2

0.7-5.1

8.1

2.7-17.8

3

2.1

0.4-6.1

7.5

1.6-20.4

1

1.3

0.0-6.9

5.0

0.1-24.9

82

1

0.4

0.0-2.5

1.6

0.0-8.7

0

0.0

0.0-2.6

0.0

0.0-8.8

1

1.3

0.0-6.9

5.0

0.1-24.9

PHR/HR-HPVs

               

66/68

6

2.7

1.0-5.8

9.7

3.6-19.9

5

3.5

1.2-8.1

12.5

4.2-26.8

1

1.3

0.0-6.9

5.0

0.1-24.9

PHR-HPVs

               

53

6

2.7

1.0-5.8

9.7

3.6-19.9

4

2.8

0.8-7.1

10.0

2.8-23.7

2

2.5

0.3-8.8

10.0

1.2-31.7

LR/PHR-HPVs

               

84/26

2

0.9

0.1-3.2

3.2

0.4-11.2

1

0.7

0.0-3.9

2.5

0.1-13.2

1

1.3

0.0-6.9

5.0

0.1-24.9

LR-HPVs

               

6

15

6.7

3.8-10.8

24.2

14.2-36.7

8

5.7

2.5-10.9

20.0

9.1-35.6

6

7.6

2.8-15.8

30.0

11.9-54.3

11

12

5.4

2.8-9.2

19.4

10.4-31.4

9

6.4

3.0-11.8

22.5

10.8-38.5

3

3.8

0.8-10.7

15.0

3.2-37.9

42

5

2.2

0.7-5.1

8.1

2.7-17.8

3

2.1

0.4-6.1

7.5

1.6-20.4

2

2.5

0.3-8.8

10.0

1.2-31.7

70

7

3.1

1.3-6.4

11.3

4.7-21.9

5

3.5

1.2-8.1

12.5

4.2-26.8

2

2.5

0.3-8.8

10.0

1.2-31.7

72

6

2.7

1.0-5.8

9.7

3.6-19.9

4

2.8

0.8-7.1

10.0

2.8-23.7

2

2.5

0.3-8.8

10.0

1.2-31.7

40/61

8

3.6

1.6-6.9

12.9

5.7-23.9

7

5.0

2.0-10.0

17.5

7.3-32.8

1

1.3

0.0-6.9

5.0

0.1-24.9

43/44

17

7.6

4.5-11.9

27.4

16.9-40.2

11

7.8

4.0-13.5

27.5

14.6-43.9

6

7.6

2.8-15.8

30.0

11.9-54.3

54/55

5

2.2

0.7-5.1

8.1

2.7-17.8

4

2.8

0.8-7.1

10.0

2.8-23.7

1

1.3

0.0-6.9

5.0

0.1-24.9

57/71

1

0.4

0.0-2.5

1.6

0.0-8.7

1

0.7

0.0-3.9

2.5

0.1-13.2

0

0.0

0.0-4.6

0.0

0.0-16.8

X

2

0.9

0.1-3.2

3.2

0.4-11.2

2

1.4

0.2-5.0

5.0

0.6-16.9

0

0.0

0.0-4.6

0.0

0.0-16.8

  1. N: total number of times, which each genotype, was detected.
  2. * Percentages referred to the total number of virus detected (223 viruses in the Total of lesions, 141 in the LASIL and 79 in HASIL).
  3. ** Percentages referred to the number of lesions infected by one or several genotypes (62 Total lesions, 40 LASIL and 20 HASIL).
  4. CI95%: 95% confidence intervals used for estimate percentages.
Back to article page

Diagnostic Pathology

ISSN: 1746-1596

Contact us